Agilon Health, Inc. current report, 11 August 2023

Agilon Health, Inc. Form 8-K Summary

Business Context and Reporting Period

Agilon Health filed a Form 8-K dated August 16, 2023, reporting an event occurring August 11, 2023. The filing concerns a change in the company’s chief accounting officer and does not report quarterly or annual financial results.

Key Financial and Operating Metrics

The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.

Material Changes Versus the Prior Comparable Period

  • Priscilla Kasenchak resigned as Chief Accounting Officer to pursue another professional opportunity.
  • The filing states that her resignation was not related to any disagreement with Agilon Health.
  • Timothy Gertsch, previously Vice President, Controller, became Chief Accounting Officer effective August 16, 2023.
  • Kasenchak was expected to remain with the company in a transitional role through September 15, 2023.

Compensation, Outlook, Risks, and Unusual Items

  • Gertsch will receive an annual base salary of $325,000 and an annual target bonus equal to 50% of base salary.
  • He will receive stock options valued at $100,000 under the Black-Scholes model and restricted stock units valued at $100,000 on the grant date, subject to continued employment and applicable vesting conditions.
  • Gertsch is also eligible for an annual equity grant under the company’s equity compensation plan, subject to board approval.
  • Gertsch, age 37, has served as Agilon Health’s Vice President, Controller since April 2022 and previously served in several accounting roles at the company.
  • The filing reports no family relationships, related-party transactions, or arrangements with other persons requiring disclosure in connection with Gertsch’s appointment.

Important Facts for Investors to Verify

  • Confirm the effective date of the chief accounting officer transition and Kasenchak’s final transition-service date.
  • Review the terms, valuation methodology, vesting schedules, and accounting treatment of Gertsch’s equity awards.
  • Assess whether the change affects future financial reporting, internal controls, or disclosure controls.
  • Monitor subsequent filings for any updates regarding the company’s accounting leadership or compensation arrangements.